ASO Author Reflections: CACNA2D1 may have a Potential as a Biomarker for Cancer Growth and as a Therapeutic Target for Gastric Cancer
- 16 April 2022
- journal article
- editorial
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (7) , 4536-4537
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Functions and Clinical Significance of CACNA2D1 in Gastric CancerAnnals of Surgical Oncology, 2022
- Roles of Ion and Water Channels in the Cell Death and Survival of Upper Gastrointestinal Tract CancersFrontiers in Cell and Developmental Biology, 2021
- Amlodipine and Verapamil, Voltage-Gated Ca2+ Channel Inhibitors, Suppressed the Growth of Gastric Cancer Stem CellsAnnals of Surgical Oncology, 2021
- CXCL11 promotes self-renewal and tumorigenicity of α2δ1+ liver tumor-initiating cells through CXCR3/ERK1/2 signalingCancer Letters, 2019